{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:53:50Z","timestamp":1790812430123,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100024159","name":"Dr. Reddy's Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024159","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017239","name":"BeiGene Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"F Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.clml.2024.12.015","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T16:23:55Z","timestamp":1735403035000},"page":"e290-e301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-4041","authenticated-orcid":false,"given":"Virginia","family":"Abello Polo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Boquimpani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-937X","authenticated-orcid":false,"given":"Luis Antonio","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Munevar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigoberto","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7827-5250","authenticated-orcid":false,"given":"Diana Marcela","family":"Cuervo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Var\u00f3n Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0082-0477","authenticated-orcid":false,"given":"Jheremy","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Idrobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-5130","authenticated-orcid":false,"given":"Paola","family":"Oma\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3426-1512","authenticated-orcid":false,"given":"Jorge","family":"Daza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-2469","authenticated-orcid":false,"given":"Julian Eduardo","family":"Pedraza Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Agudelo L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-6911","authenticated-orcid":false,"given":"Guillermo E.","family":"Quintero-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-3301","authenticated-orcid":false,"given":"Mario","family":"Correa Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-164X","authenticated-orcid":false,"given":"William Armando","family":"Mantilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-9053","authenticated-orcid":false,"given":"Kenny Mauricio","family":"G\u00e1lvez C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Saavedra Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8447-6553","authenticated-orcid":false,"given":"Mauricio","family":"Alzate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Fernando","family":"Lobat\u00f3n Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.clml.2024.12.015_bib0001","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population","volume":"34","author":"Bower","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clml.2024.12.015_bib0002","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41375-020-0842-9","article-title":"Expert opinion\u2014Management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.clml.2024.12.015_bib0003","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"10.1016\/j.clml.2024.12.015_bib0004","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1007\/s00277-015-2314-2","article-title":"Epidemiology of chronic myeloid leukaemia: an update","volume":"94","author":"H\u00f6glund","year":"2015","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.clml.2024.12.015_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40164-020-00185-z","article-title":"Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study","volume":"9","author":"Ning","year":"2020","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.clml.2024.12.015_bib0006","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/GO.21.00155","article-title":"National cancer information system within the framework of Health insurance in Colombia: a real-world data approach to evaluate access to cancer care","volume":"7","author":"Hern\u00e1ndez Vargas","year":"2021","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"10.1016\/j.clml.2024.12.015_bib0007","first-page":"128","article-title":"Cancer risk management in Colombia","volume":"49","author":"Ram\u00edrez-Barbosa","year":"2016","journal-title":"Colomb M\u00e9dica CM"},{"key":"10.1016\/j.clml.2024.12.015_bib0008","unstructured":"Situaci\u00f3n del c\u00e1ncer en la poblaci\u00f3n adulta atendida en el SGSSS de Colombia 2022. Cuenta de alto costo. 244-247 [Accessed January 16, 2025]. Available from: https:\/\/cuentadealtocosto.org\/publicaciones\/situacion-del-cancer-en-la-poblacion-adulta-atendida-en-el-sgsss-de-colombia-2022\/."},{"key":"10.1016\/j.clml.2024.12.015_bib0009","unstructured":"Salud en las Am\u00e9ricas. 2022 [Accessed February 28, 2024]. Perfil de Pa\u00eds - Colombia. Available from: https:\/\/hia.paho.org\/es\/paises-2022\/perfil-colombia."},{"key":"10.1016\/j.clml.2024.12.015_bib0010","unstructured":"N\u00fa\u00f1ez J. Logros en equidad del sistema de salud y la reforma en Colombia. 2023 [Accessed February 28, 2024]. Available from: http:\/\/www.repository.fedesarrollo.org.co\/handle\/11445\/4434."},{"key":"10.1016\/j.clml.2024.12.015_bib0011","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/S2152-2650(20)30827-2","article-title":"CML-319: iimpact of insurance differences in outcomes in Colombian patients with chronic myeloid leukemia (CML)","volume":"20","author":"Abello","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.clml.2024.12.015_bib0012","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/j.clml.2021.12.009","article-title":"Real-world evidence of epidemiology and clinical outcomes in multiple myeloma, findings from the registry of hemato-oncologic malignancies in Colombia, observational study","volume":"22","author":"Abello","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.clml.2024.12.015_bib0013","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2024.12.015_bib0014","series-title":"A Language and Environment for Statistical Computing","year":"2024"},{"key":"10.1016\/j.clml.2024.12.015_bib0015","series-title":"RStudio: Integrated Development Environment for R. Version 2023.09.1","year":"2024"},{"key":"10.1016\/j.clml.2024.12.015_bib0016","unstructured":"Wickham H., Romain F., Henry L., M\u00fcller K., Davis V. dplyr: a grammar of data manipulation. 2023 [Accessed February 28, 2024]. Available from: https:\/\/CRAN.R-project.org\/package=dplyr."},{"key":"10.1016\/j.clml.2024.12.015_bib0017","unstructured":"Therneau T.M. A package for survival analysis. 2024. (R package version) [Accessed February 28, 2024]. Available from: https:\/\/CRAN.R-project.org\/package=survival."},{"issue":"21","key":"10.1016\/j.clml.2024.12.015_bib0018","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1002\/cncr.25273","article-title":"Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET)","volume":"116","author":"Cortes","year":"2010","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clml.2024.12.015_bib0019","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11899-021-00654-0","article-title":"Challenges in chronic myeloid leukemia management in South America","volume":"16","author":"Pagnano","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"issue":"20","key":"10.1016\/j.clml.2024.12.015_bib0020","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","article-title":"Final 5-year study results of DASISION: the Dasatinib versus Imatinib study in treatment-na\u00efve chronic myeloid leukemia patients trial","volume":"34","author":"Cortes","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.clml.2024.12.015_bib0021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41375-020-01111-2","article-title":"Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: eNESTnd 10-year analysis","volume":"35","author":"Kantarjian","year":"2021","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2024.12.015_bib0022","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3324\/haematol.2017.174953","article-title":"Treatment outcome in a population-based, \u201creal-world\u201d cohort of patients with chronic myeloid leukemia","volume":"102","author":"Geelen","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.clml.2024.12.015_bib0023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.24591","article-title":"A population-based study of chronic myeloid leukemia patients treated with imatinib in first line","volume":"92","author":"Castagnetti","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2024.12.015_bib0024","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/10781552231217694","article-title":"Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia","volume":"30","author":"Collins","year":"2024","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.clml.2024.12.015_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ejh.13524","article-title":"Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic-phase CML in clinical practice: 3-year European SIMPLICITY data","volume":"106","author":"Gambacorti-Passerini","year":"2021","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.clml.2024.12.015_bib0026","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.clml.2023.05.009","article-title":"Low-dose dasatinib (50 mg Daily) frontline therapy in newly diagnosed chronic phase chronic myeloid leukemia: 5-year follow-up results","volume":"23","author":"Gener-Ricos","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.clml.2024.12.015_bib0027","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1186\/s12885-022-10241-y","article-title":"A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia","volume":"22","author":"Cantoni","year":"2022","journal-title":"BMC Cancer"},{"issue":"23","key":"10.1016\/j.clml.2024.12.015_bib0028","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1182\/bloodadvances.2020003235","article-title":"Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel","volume":"5","author":"Pavlovsky","year":"2021","journal-title":"Blood Adv"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:33:42Z","timestamp":1751398422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024024649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2152265024024649"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.12.015","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}